By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Fraud Victims who invested in the fraudulent cryptocurrency OneCoin between 2014 and 2019 and experienced a net loss may be eligible to receive compensation through the Department of Justice’s petition for remission process
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > Fraud Victims who invested in the fraudulent cryptocurrency OneCoin between 2014 and 2019 and experienced a net loss may be eligible to receive compensation through the Department of Justice’s petition for remission process
Fraud Victims who invested in the fraudulent cryptocurrency OneCoin between 2014 and 2019 and experienced a net loss may be eligible to receive compensation through the Department of Justice’s petition for remission process
News

Fraud Victims who invested in the fraudulent cryptocurrency OneCoin between 2014 and 2019 and experienced a net loss may be eligible to receive compensation through the Department of Justice’s petition for remission process

Last updated: 14/04/2026 3:37 PM
Published: 14/04/2026
Share
SHARE

PHILADELPHIA, April 13, 2026 /PRNewswire/ — The following statement is being issued by Kroll Settlement Administration on behalf of the United States Department of Justice regarding the OneCoin Cryptocurrency Remission Program (“Remission Program”).

- Advertisement -

What is this about?

- Advertisement -

The Department of Justice has commenced a petition for remission process to compensate fraud victims who invested in the fraudulent cryptocurrency platform, OneCoin, between 2014 and 2019. The United States Attorney’s Office for the Southern District of New York filed a number of OneCoin-related prosecutions in the Southern District of New York.

- Advertisement -

Between 2014 and 2019, Ruja Ignatova and Karl Sebastian Greenwood, co-founders of OneCoin Ltd., and others, orchestrated a large, international cryptocurrency investment scheme defrauding investors from around the globe. The scheme involved the marketing and sale of fraudulent cryptocurrency, resulting in significant financial losses for victims worldwide. The United States Attorney’s Office in the Southern District of New York pursued criminal forfeiture of proceeds of the fraud scheme and the net proceeds of those forfeited assets will be available to compensate victims through the remission process. Victims affected by the OneCoin scheme may file petitions for remission to receive compensation.

- Advertisement -

Who is eligible for compensation?

- Advertisement -

Victims who purchased OneCoin cryptocurrency between 2014 and 2019 and experienced a net loss of the investment when accounting for any completed withdrawals or collateral recoveries may be eligible to receive compensation in this matter. However, submission of a petition for remission does not guarantee payment. Neither the Department of Justice nor the Remission Administrator charge fees for you to file a petition or to participate in the remission process. Additionally, you do not need an attorney to file a petition.

- Advertisement -

What options do victims have?

- Advertisement -
  • Submit a Petition Form by June 30, 2026: To participate in this Remission Program, you must submit a completed petition form. As part of your submission, you will be asked to verify monetary losses that were incurred as a result of the scheme. Documentation to support all claimed losses must be included with the submission of your petition form. Petitions for remission can be submitted by mail or online on www.onecoinremission.com.
  • Do Nothing: If you do not wish to participate in the Remission Program, you do not need to file a petition form. No further action is necessary. If you do not submit a petition for remission, you will not be considered in the Remission Program.

Get More Information

- Advertisement -

This is only a summary. More details about the petition for remission process and instructions on how to submit a petition are available as follows:

- Advertisement -

Visit: www.onecoinremission.com

- Advertisement -

Call: 1-833-421-9748

- Advertisement -

Email: info@OneCoinRemission.com

- Advertisement -

Write: OneCoin Remission, c/o Kroll Settlement Administration LLC, P.O. Box 225391, New York, NY 10150-5391

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/fraud-victims-who-invested-in-the-fraudulent-cryptocurrency-onecoin-between-2014-and-2019-and-experienced-a-net-loss-may-be-eligible-to-receive-compensation-through-the-department-of-justices-petition-for-remission-process-302739468.html

- Advertisement -
Satguru Travel Issues Clarification to Address Misinformation, Reaffirms Faith in Judicial Process and Corporate Integrity
CATALYX SPACE SECURES $5.4 MILLION SEED ROUND TO BUILD FOR THE NEXT ERA OF ORBITAL LOGISTICS
Global Excel Acquires First Assistance to Strengthen Assistance Services and Expand in the Asia-Pacific Market
Introducing Miutine, the new irreverent, fragrance by Miu Miu
Bybit launches in the UK to meet rising demand for digital-asset platforms
TAGGED:20142019andbetweencompensationcryptocurrencydepartmenteligibleexperiencedforfraudfraudulentinvestedjustice’slossmaynetnewsonecoinpetitionprocessreceiveremissionthethroughvictimswho
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
Health

InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China

GlobeNews Wire
GlobeNews Wire
13/02/2026
NYSE Content Update: Canada-Based MDA Space Shoots for the Stars in its NYSE Debut
Colgate’s Bright Smiles, Bright Futures Program Celebrates Reaching Over Two Billion Children and Their Families Around the World
Young Minds Explore Creativity, Teamwork, and Healthy Habits at Manipal Hospital Yelahanka’s Children’s Day Event
KLEVV LAUNCHES ENHANCED SSD LINEUP: CRAS C925G, CRAS C910G NVME SSDS, AND NEO N410+ SATA SSD
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?